Hi Jerry. Looks like a private biotech with research funding from the EU, and located in the Czech Republic:
ESSENCE LINE is a biotech company with its own research & development, founded in 2002. Our team includes professionals with analytical and technological background focusing on market-oriented development, products and services primarily in the areas related to REACH, genotoxicity, endocrine disruptors, cytotoxicity, DNA diagnostics and other biochemical analysis. Accompanied with complete training and technical documentation, we deliver and master advanced micro fluctuation assays (genotoxicity, endocrine disruptors, cytotoxicity), DNA Diagnostics (RT-PCR, micro/nanoarrays), technology transfers and supplies of turnkey projects.
Over the last decade, we have established ourselves in leading academic institutions and private pharma and biotech companies both in the Czech Republic and worldwide delivering our products and services on a turnkey level. ESSENCE LINE as SMEs has participated in EU-supported research projects focused on developing new diagnostic tools and advanced laboratory facilities especially focusing on health care and environment.
Microarrays
Our team has been specialized to protein and DNA microarrays for over 10 years. In cooperation with Arrayit and different research insitutes (Masaryk University, Verona University, Ceitec, Biocev, ICT Prague, Charles University etc.), we have been providing unparallel custom microarray design and production, their analyses and bioinformatic interpretation, moreover, deliveries from key components (microarrayers, scanners, hybstations etc.) to entire Biochip labs (Biochip platforms) .
Market Data 
Markets 
AI
